aTyr Pharma Announces Second Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT(TM) Study in Pulmonary Sarcoidosis

Stock Information for aTyr Pharma Inc.

Loading

Please wait while we load your information from QuoteMedia.